More women are turning to an experimental at-home abortion program to abort their unborn babies during the coronavirus crisis. The TelAbortion experiment, approved by the Food and Drug Administration (FDA), mails abortion drugs to women in 13 states. In some cases, the women may never see a doctor in person before aborting their unborn babies. As states restrict travel, health care, business and other things deemed “non-essential” due to the coronavirus, more women are contacting the experimental program. New York Daily News reports TelAbortion saw a 30% uptick in “virtual visits” between February and March. The pro-abortion has group mailed...